financetom
Business
financetom
/
Business
/
Viatris eye therapy fails to meet late-stage trial goal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Viatris eye therapy fails to meet late-stage trial goal
Jul 18, 2025 4:24 AM

July 18 (Reuters) - Viatris ( VTRS ) said on Friday that

its experimental ophthalmic ointment did not meet the main goal

of a late-stage study in patients with an eye condition that

causes inflammation.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Fiserv Issues Medium-Term Financial Outlook Through 2029
Fiserv Issues Medium-Term Financial Outlook Through 2029
May 14, 2026
09:17 AM EDT, 05/14/2026 (MT Newswires) -- Fiserv ( FISV ) issued Thursday its medium-term financial outlook and said it expects adjusted earnings per share to grow in the double-digit range for 2027 to 2029. Adjusted earnings are expected to exceed $12 by 2029. Four analysts polled by FactSet expect $12.64. The company also projected adjusted revenue to grow 4%...
Sabre Prices $150 Million Exchangeable Senior Notes Offering
Sabre Prices $150 Million Exchangeable Senior Notes Offering
May 14, 2026
09:16 AM EDT, 05/14/2026 (MT Newswires) -- Sabre (SABR) said Thursday its unit, Sabre GLBL, issued $150 million in 7% exchangeable senior notes due 2031. The debt matures May 15, 2031, and proceeds will be used to repurchase $100 million of outstanding 7.32% notes due 2026, the company said. The notes are fully guaranteed by the parent and another unit,...
Form 8.3
Form 8.3
May 14, 2026
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:   Sand Grove Capital Management LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming...
CHEPLAPHARM to Accelerate Global Supply Chain Digitalization with TraceLink MINT
CHEPLAPHARM to Accelerate Global Supply Chain Digitalization with TraceLink MINT
May 14, 2026
The German pharmaceutical company unifies its digital partner network, laying the foundation for AI-driven supply chain orchestration BOSTON, May 14, 2026 /PRNewswire/ -- TraceLink, the world's largest Agentic Business Network, today announced that the German-based but globally active CHEPLAPHARM Group, a world leader in the acquisition of original preparations from the research-based pharmaceutical industry, is going live on the TraceLink...
Copyright 2023-2026 - www.financetom.com All Rights Reserved